Siglec-15 and Its Related Immune Phenotypes Can Predict the Efficacy of Breast Cancer with Neoadjuvant Chemotherapy

被引：0
|
作者：
Chen, Honglei [1 ]
Tian, Sufang [2 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Ctr Pathol & Mol Diagnost, Wuhan, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Wuhan, Peoples R China
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
125
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [21] Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?
    B. Schaefgen
    M. Mati
    H. P. Sinn
    M. Golatta
    A. Stieber
    G. Rauch
    A. Hennigs
    H. Richter
    C. Domschke
    F. Schuetz
    C. Sohn
    A. Schneeweiss
    Joerg Heil
    Annals of Surgical Oncology, 2016, 23 : 789 - 795
  • [22] Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?
    Schaefgen, B.
    Mati, M.
    Sinn, H. P.
    Golatta, M.
    Stieber, A.
    Rauch, G.
    Hennigs, A.
    Richter, H.
    Domschke, C.
    Schuetz, F.
    Sohn, C.
    Schneeweiss, A.
    Heil, Joerg
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (03) : 789 - 795
  • [23] Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer
    Shafi, Saba
    Aung, Thazin Nwe
    Xirou, Vasiliki
    Gavrielatou, Niki
    Vathiotis, Ioannis A.
    Fernandez, Aileen
    Moutafi, Myrto
    Yaghoobi, Vesal
    Herbst, Roy S.
    Liu, Linda N.
    Langermann, Sol
    Rimm, David L.
    LABORATORY INVESTIGATION, 2022, 102 (10) : 1143 - 1149
  • [24] Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
    Uematsu, Takayoshi
    Kasami, Masako
    Watanabe, Junichiro
    Takahashi, Kaoru
    Yamasaki, Seiji
    Tanaka, Kumiko
    Tadokoro, Yukiko
    Ogiya, Akiko
    BREAST CANCER, 2011, 18 (04) : 309 - 313
  • [25] Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
    Takayoshi Uematsu
    Masako Kasami
    Junichiro Watanabe
    Kaoru Takahashi
    Seiji Yamasaki
    Kumiko Tanaka
    Yukiko Tadokoro
    Akiko Ogiya
    Breast Cancer, 2011, 18 : 309 - 313
  • [26] Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI
    Liu, Yongguang
    Wu, Mingxiang
    Tan, Wenyong
    Gong, Jingshan
    Ma, Jie
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [27] Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer
    Ahn, Jee Hyun
    Go, Jieon
    Lee, Suk Jun
    Kim, Jee Ye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Vivian Youngjean
    Yoon, Jung Hyun
    Kim, Min Jung
    Park, Seho
    KOREAN JOURNAL OF RADIOLOGY, 2023, 24 (05) : 384 - 394
  • [28] Can breast MRI predict pathologic response following neoadjuvant chemotherapy for breast cancer? A retrospective cohort study
    Kwak, Lily
    Santa -Maria, Cesar
    Di Carlo, Philip
    Mullen, Lisa A.
    Myers, Kelly S.
    Oluyemi, Eniola
    Panigrahi, Babita
    Rossi, Joanna
    Ambinder, Emily B.
    CLINICAL IMAGING, 2023, 101 : 105 - 112
  • [29] Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
    Stoll, Gautier
    Enot, David
    Mlecnik, Bernhard
    Galon, Jerome
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2014, 3 (02):
  • [30] Mammographic density to predict response to neoadjuvant chemotherapy for breast cancer
    Di Cosimo, S.
    Depretto, C.
    Miceli, R.
    Baili, P.
    Sant, M.
    Pruneri, G.
    Vingiani, A.
    Folli, S.
    Bini, M.
    De Santis, M. C.
    Scaperrotta, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S49 - S49
12345